Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3024% below fair value
$17.06−1.42 (-7.68%)
Close on Nov 17, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care gross margin
Gross margin is gross profit as a percentage of revenue.
Tandem Diabetes Care's gross margin for the twelve months ending Jun 30, 2026 was 56.0%. For fiscal 2025 it was 53.8%, against 52.1% the year before. The highest annual figure on record is 53.8% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 53.8% | +1.7 |
| FY2024 | Dec 31, 2024 | 52.1% | +2.9 |
| FY2023 | Dec 31, 2023 | 49.2% | −2.4 |
| FY2022 | Dec 31, 2022 | 51.5% | −2.0 |
| FY2021 | Dec 31, 2021 | 53.5% | +1.3 |
| FY2020 | Dec 31, 2020 | 52.2% | −1.4 |
| FY2019 | Dec 31, 2019 | 53.6% | +4.8 |
| FY2018 | Dec 31, 2018 | 48.9% | +7.9 |
| FY2017 | Dec 31, 2017 | 41.0% | +13.0 |
| FY2016 | Dec 31, 2016 | 28.0% | −8.5 |
| FY2015 | Dec 31, 2015 | 36.5% | +5.8 |
| FY2014 | Dec 31, 2014 | 30.7% | +9.4 |
| FY2013 | Dec 31, 2013 | 21.3% | +75.7 |
| FY2012 | Dec 31, 2012 | -54.5% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 56.9% | +4.6 |
| Q1 FY2026 | Mar 31, 2026 | 55.3% | +4.8 |
| Q4 FY2025 | Dec 31, 2025 | 57.7% | +2.0 |
| Q3 FY2025 | Sep 30, 2025 | 53.9% | +2.8 |
| Q2 FY2025 | Jun 30, 2025 | 52.3% | +1.5 |
| Q1 FY2025 | Mar 31, 2025 | 50.5% | +1.1 |
| Q4 FY2024 | Dec 31, 2024 | 55.7% | +8.3 |
| Q3 FY2024 | Sep 30, 2024 | 51.1% | +2.7 |
| Q2 FY2024 | Jun 30, 2024 | 50.8% | −1.1 |
| Q1 FY2024 | Mar 31, 2024 | 49.4% | +0.4 |
| Q4 FY2023 | Dec 31, 2023 | 47.4% | −5.0 |
| Q3 FY2023 | Sep 30, 2023 | 48.4% | −2.7 |
| Q2 FY2023 | Jun 30, 2023 | 51.9% | +1.0 |
| Q1 FY2023 | Mar 31, 2023 | 48.9% | −2.8 |
| Q4 FY2022 | Dec 31, 2022 | 52.4% | −1.8 |
| Q3 FY2022 | Sep 30, 2022 | 51.1% | −2.8 |
| Q2 FY2022 | Jun 30, 2022 | 50.9% | −2.8 |
| Q1 FY2022 | Mar 31, 2022 | 51.8% | −0.2 |
| Q4 FY2021 | Dec 31, 2021 | 54.2% | +0.3 |
| Q3 FY2021 | Sep 30, 2021 | 53.9% | +1.0 |
| Q2 FY2021 | Jun 30, 2021 | 53.7% | +3.9 |
| Q1 FY2021 | Mar 31, 2021 | 52.0% | +0.6 |
| Q4 FY2020 | Dec 31, 2020 | 53.9% | −1.7 |
| Q3 FY2020 | Sep 30, 2020 | 52.8% | −0.7 |
| Q2 FY2020 | Jun 30, 2020 | 49.8% | −3.7 |
| Q1 FY2020 | Mar 31, 2020 | 51.3% | +0.8 |
| Q4 FY2019 | Dec 31, 2019 | 55.6% | +1.1 |
| Q3 FY2019 | Sep 30, 2019 | 53.5% | +6.4 |
| Q2 FY2019 | Jun 30, 2019 | 53.5% | +9.3 |
| Q1 FY2019 | Mar 31, 2019 | 50.5% | +8.7 |
| Q4 FY2018 | Dec 31, 2018 | 54.5% | +11.2 |
| Q3 FY2018 | Sep 30, 2018 | 47.1% | +3.1 |
| Q2 FY2018 | Jun 30, 2018 | 44.2% | +6.7 |
| Q1 FY2018 | Mar 31, 2018 | 41.8% | +6.2 |
| Q4 FY2017 | Dec 31, 2017 | 43.4% | +8.5 |
| Q3 FY2017 | Sep 30, 2017 | 44.0% | +56.8 |
| Q2 FY2017 | Jun 30, 2017 | 37.5% | – |
| Q1 FY2017 | Mar 31, 2017 | 35.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 34.8% | – |
| Q3 FY2016 | Sep 30, 2016 | -12.8% | – |
See a number that looks wrong?